GDF15 and cancer: TOLE can inhibit cell growth in cancer cells through cyclooxygenase-independent pathways including inhibition of ErbB2 expression [46], activation or ATF3 [47], or induction of NSAID-activated gene-1 (NAG-1) [48] and EGR1 [24].